Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Covance Inc.

Division of Laboratory Corp. of America Holdings

Latest From Aragon Pharmaceuticals Inc.

J&J’s Stoffels On Actelion’s ‘Exquisite’ Researchers, India TB R&D Plans

J&J’s chief scientific officer Dr. Paul Stoffels tells Scrip that flexibility is a hallmark of how the company goes about its collaborations, including the new $30bn deal with Actelion. Stoffels is also hoping to progress the science for a new TB medicine via a unique collaboration in India.

Commercial Strategy

J&J’s $30bn For Actelion Buys Immediate And Longer-Term Value

In this tale of two companies, it's the best of times and the best of times. J&J gets immediate value by acquiring Actelion's blockbuster PAH franchise and its late-stage pipeline, while its stake in an Actelion spinout offers longer-term potential.

M & A Deals

venBio's $315m Pharma-Backed Fund Seeks Broad Range Of Investments

VenBio has $315m in new cash to invest in a broad array of therapeutics developers now that it has closed its second venture capital fund, which raised $65m more than the VC firm originally intended and reflects big pharma's increasing commitment to backing early-stage life science companies.

Companies Business Strategies

Monetizing Focus: Tesaro Adds Runway By Out-licensing Niraparib In Prostate Cancer

Janssen pays $40m up front with sizeable earn-outs for right to develop PARP inhibitor in prostate cancer, while Tesaro will continue with development of niraparib in ovarian, breast and lung cancer.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Laboratory Corp. of America Holdings
  • Senior Management
  • Joseph Herring, Chmn & CEO
    Alison A Cornell, Corp, VP & CFO
    Nigel Brown, Corp. VP, Bus. Dev. & Strategy
    John Watson, SVP, Pres., Strat. Partnering & Chief. Comm. Offic
    Rick Cimino, EVP, Group Pres., Clinical Dev.
  • Contact Info
  • Covance Inc.
    Phone: (609) 419-2240
    210 Carnegie Center
    Princeton, NJ 08540